TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2013

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536.

Edward S Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.